Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Repligen Corp RGEN

Technology Scientific & Technical Instruments
Repligen Corporation is a global life sciences company that develops and commercializes bioprocessing technologies and systems. The Company's bioprocessing business consists of four main franchises: filtration (including fluid management); chromatography; process analytics, and proteins. Its filtration products are used in process development and process scale (clinical and commercial... see more

Recent & Breaking News (NDAQ:RGEN)

Repligen to Host Investor & Analyst Event on October 16

GlobeNewswire October 10, 2014

Leading Health Care Stock for Small-Cap Stars is Provectus Biopharmaceuticals Inc. (PVCT) for August 18

Equities.com August 18, 2014

Leading Small-Cap Stars Health Care Stock for August 11 Morning Session is Boston Therapeutics Inc (BTHE)

Equities.com August 11, 2014

Repligen Reports Second Quarter 2014 Financial Results

GlobeNewswire August 11, 2014

Repligen to Report Second Quarter 2014 Financial Results

GlobeNewswire July 28, 2014

Repligen Hires Jon K. Snodgres as Chief Financial Officer

GlobeNewswire July 15, 2014

Repligen Appoints Nicolas M. Barthelemy to Board of Directors

GlobeNewswire June 12, 2014

Repligen Acquires Bioprocessing Business of Refine Technology

GlobeNewswire June 3, 2014

Repligen to Present at Jefferies 2014 Global Healthcare Conference

GlobeNewswire May 28, 2014

Repligen Reports First Quarter 2014 Financial Results

GlobeNewswire May 8, 2014

Repligen Hires Former Life Technologies Executive Tony J. Hunt as Chief Operating Officer

GlobeNewswire May 6, 2014

Repligen to Report First Quarter 2014 Financial Results

GlobeNewswire April 25, 2014

Repligen Corporation Set to Join the S&P SmallCap 600

PR Newswire April 15, 2014

Repligen Launches OPUS(R) Ready-to-Use Chromatography Columns With Largest Capacity Available on the Market

GlobeNewswire March 26, 2014

Repligen Reports Full Year and Fourth Quarter 2013 Financial Results

GlobeNewswire March 6, 2014

Repligen to Report Fourth Quarter and Fiscal Year 2013 Financial Results

GlobeNewswire February 25, 2014

Repligen Announces Asset Purchase Agreement With BioMarin for HDACi Portfolio

Globe Newswire January 21, 2014

Repligen to Present at the 25th Annual Piper Jaffray Healthcare Conference

Globe Newswire November 26, 2013

Repligen Appoints Biogen Idec Executive John G. Cox to Board of Directors

Globe Newswire November 19, 2013

Repligen Reports Third Quarter 2013 Financial Results

Globe Newswire November 7, 2013